Tesaro's Series B Round

Tesaro raised a round of funding on June 21, 2011.

Tesaro is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients. The Company intends to identify, acquire and develop promising drug candidates; and to comm…

Articles about Tesaro's Series B Round: